Read: AION Labs, In Continued Partnership with BioMed X, Launches First 2024 Global Call for Applications: AI/ML Platform for Targeting RNA with Small Molecules AION Labs, In Continued Partnership with BioMed X, Launches First 2024 Global Call for Applications: AI/ML Platform for Targeting RNA with Small Molecules Feb 20, 2024
Read: New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine New T-FINDER Platform Provides Deep Insights Into T Cell Responses Against Novel Cancer Vaccine Feb 6, 2024
Read: BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research BioMed X Institute and Ono Pharmaceutical Launch New Collaboration in Cancer Research Dec 19, 2023
Read: BioMed X Launches a New Call for Application in Autoimmune Disease Research BioMed X Launches a New Call for Application in Autoimmune Disease Research Nov 7, 2023
Read: BioMed X and AbbVie Start New Research Project in the USA BioMed X and AbbVie Start New Research Project in the USA Oct 31, 2023
Read: BioMed X Institute Starts Its First Research Project with Sanofi on Artificial Intelligence for Drug Development BioMed X Institute Starts Its First Research Project with Sanofi on Artificial Intelligence for Drug Development Jun 29, 2023
Read: AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery May 25, 2023
Read: BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus BioMed X Launches XSeed Labs in the US with Boehringer Ingelheim – a New Model for Building an External Innovation Ecosystem on an Industry Campus Apr 27, 2023
Read: BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies Apr 4, 2023
Read: BioMed X Launches New T Cell Immunology Discovery Platform BioMed X Launches New T Cell Immunology Discovery Platform Feb 14, 2023
Read: BioMed X and AbbVie Extend Research Collaboration in the US BioMed X and AbbVie Extend Research Collaboration in the US Jan 16, 2023
Read: BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development Oct 24, 2022
Read: BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology BioMed X Institute and Healthcare Business of Merck KGaA, Darmstadt, Germany, Start New Research Project in Oncology Aug 1, 2022
Read: AION Labs, in Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations AION Labs, in Continued Partnership with BioMed X, Launches Fourth Global Call for Application: Prediction of Clinical Trial Outcome in Cancer Patient Populations Jun 29, 2022
Read: BioMed X Institute Launches Ukraine Refugee Funding Program BioMed X Institute Launches Ukraine Refugee Funding Program May 18, 2022
Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology BioMed X Institute and Merck KGaA, Darmstadt, Germany, start second research project in immunology Mar 15, 2022
Read: BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development BioMed X Institute and Boehringer Ingelheim start new research project in brain sensor development Mar 1, 2022
Read: AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies AION Labs, Powered by BioMed X, Launches Third Global Call for Application: Artificial Intelligence for Design and Optimization of Antibodies for Targeted Therapies Feb 14, 2022
Read: BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology BioMed X Institute and Merck KGaA, Darmstadt, Germany, extend collaboration in oncology Feb 1, 2022
Read: AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates AION Labs, Powered by BioMed X, Launches Second Global Call for Application: Artificial Intelligence for Clinical Trial Readiness of Drug Candidates Dec 13, 2021
Read: BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany BioMed X Institute successfully completes fourth project in oncology in collaboration with Merck KGaA, Darmstadt, Germany Nov 2, 2021
In the Media In the Media Media is constantly reporting on BioMed X Institute and its work. Read our current media coverage. Read more
Our Events Our Events Interested to learn more about our innovation model and our research projects? Check out our list of events. Read more
